https://www.selleckchem.com/pr....oducts/Nanchangmycin
1 and 4.54 μg/mL, respectively. Additionally, Triton X-100, Tween 20, and Tween 80 strongly inhibit hOAT3 with IC50 values ≤31.0 μg/mL.The present study is significant in understanding the excipient-drug interactions and provides valuable information for excipient selection in drug development.Background In 2013, eribulin was reimbursed under a coverage with evidence development (CED) as third or later chemotherapy line for advanced breast cancer (ABC) patients in the Netherlands because of uncertain cost effectiveness. In 2016, t
Curtir
Comentario
Compartilhar
